Tag: Ards

Over 3 million people worldwide are affected by respiratory failure each year, with mortality rates as high as 40% in severe cases. The first line treatment for respiratory failure involves a rapid, combined approach of immediate ventilatory support and targeted pharmacological intervention to address the root cause.

Inhaled nitric oxide (iNO) improves oxygenation and reduces the need for ECMO in term infants with hypoxic respiratory failure [1.8.5]. A critical phase of this therapy is learning how to wean iNO safely to prevent complications like rebound pulmonary hypertension.